© Copyright Nostre Net
The cerebral
palsy market trends is anticipated to reach USD 3,287.51 Million by 2030 at
3.20% CAGR during the forecast period 2022-2030.
Cerebral palsy is defined as a group of
disorders that affect muscle movement and coordination, which in many cases,
impairs vision, hearing, sensation and others senses. Cerebral palsy is a
congenital disorder of movement, muscle tone or posture and can affect a
person’s posture, balance and ability to move, communicate, eat, sleep and
learn. According to the Centre for Disease Control 1 to 4 out of every 1,000
children across the globe are affected by cerebral palsy, thereby creating a
strong demand for dia gnosis, and treatment for the condition which will drive
growth for cerebral palsy market.
Competitive Overview:
Allergen Plc, Cellular Biomedicine Group,
Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories,
Acorda Therapeutics, Inc., Medtronic, Meridigen Biotech Co., Ltd., GW
Pharmaceuticals Plc, and Cell Cure Neurosciences Ltd. are some of the key
players in the global cerebral palsy market.
Segmentation
The cerebral palsy market has been
segmented into type, diagnosis, and treatment.
On the basis of type, cerebral palsy market
has been segmented into hypotonic cerebral palsy, spastic cerebral palsy,
ataxic cerebral palsy, dyskinetic cerebral palsy, and mixed cerebral palsy.
By diagnosis, CP market segmentation
includes imaging tests and others. The imaging tests segment has been further
classified into computed tomography, magnetic resonance imaging (MRI), cranial
ultrasound, and electroencephalogram.
Based on treatment, cerebral palsy market
has been segmented into therapy, medication, surgery, cerebral palsy drugs and
others.
Regional Market Summary
Geographically, the Americas region is anticipated
to dominate the global cerebral
palsy market Report owing to a well-developed healthcare sector, rising
prevalence of cerebral palsy and growing healthcare expenditure. Additionally,
favorable reimbursement scenario in this region and a relatively large number
of research and development (R&D) activities contributes to the growth of
the market.
Europe is expected to hold the second
largest position in the global cerebral palsy market. The market growth in this
region is attributed to the growing prevalence of cerebral palsy, availability
of funds for research, and increasing healthcare expenditure. According to the
data stated by the National Institute for Health and Care Excellence (NICE) in
2017, in the UK, it is estimated that 1 in 400 babies are born with cerebral
palsy. It also stated that approximately 1,800 children diagnosed with CP each
year.
The cerebral palsy market in Asia-Pacific
region consists of countries namely China, Japan, Republic of Korea, India,
Australia and Rest of Asia-Pacific. Asia-Pacific is anticipated to be the
fastest growing region in the market due to the presence of a huge patient
population, continuously developing economies, rising prevalence of cerebral
palsy and increasing government funding for the healthcare sector.
On the other hand, the Middle East &
Africa has the least share of the market. Majority of the market of this region
is expected to be held by the Middle East region due to a well-developed
healthcare sector and growing government initiatives for the healthcare sector.
About US:
Market Research Future (MRFR), enable customers to
unravel the complexity of various industries through Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
The Wall